Chiao et al gained further insights of the role of plasma biomarkers in association to cardiac aging phenotypes. The authors observed significantly higher plasma levels of inflammatory markers in the senescent compared with the adult C57/BL6J mice. Among them, matrix metalloproteinase-9 (MMP9) correlated with the increase in end-diastolic dimensions that occurred with senescence. Dual labeling immunohistochemistry of Mac-3 and MMP9 in the left ventricle sections gave further evidence that macrophages were the major contributor of MMP9 in the senescent left ventricle. The authors conclude that MMP9 is a potential plasma markers for cardiac aging. 1 I am interested if the authors considered the preanalytical issues that are known to affect MMP9 measurements. In the study, mice were euthanized under terminal anesthesia. Heparin was injected intraperitoneally, before arterial blood sampling from the carotid artery. Blood was then centrifuged for 5 minutes to prepare plasma samples.
